Last reviewed · How we verify
NCT03498274
A Comparison of a Currently Marketed Hearing Aid Programmed With Two Different Fitting Methods
NA trial testing Fitting System in Hearing Loss in 14 participants. Terminated before completion.
11 June 2018
Quick facts
| Lead sponsor | Bernafon AG |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 14 |
| Start date | 19 March 2018 |
| Primary completion | 11 June 2018 |
| Estimated completion | 11 June 2018 |
| Sites | 2 locations across Switzerland |
Drugs / interventions tested
- Fitting System
- Traditional Fitting System
Conditions studied
- Hearing Loss — all drugs for Hearing Loss →
Sponsor
Bernafon AG
Who can join
18 and older, any sex, with Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is designed to investigate the benefits of the hearing aid in the laboratory and in daily life when fitted with two different methods. Subjective and objective evaluations will be made. The aim is to show the benefits of the hearing aids with both fitting methods with the help of data obtained, and to improve the available fitting methods in order to further increase the benefit for people with hearing disorders in situations where the standard method and those trained to perform it are not available.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03498274
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hearing Loss
Currently open trials in the same condition.
- NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation · NA · recruiting
- NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
- NCT07218913 — Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III · Phase 1 · recruiting
- NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit · NA · recruiting
- NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting
Other Bernafon AG trials
Trials by the same sponsor.
- NCT04939259 — A Comparative Clinical Investigation of Musician's Preference With Hearing Aids · NA · completed
- NCT04374851 — A Comparative Clinical Investigation of Two Hearing Instrument Digital Signal Processing · NA · completed
- NCT04147442 — A Standard Music Program Compared to an Optimized Music Program · NA · completed
- NCT04146272 — A Comparison of a New Acoustic Feedback Canceller in Hearing Aids With the Current System · NA · completed
- NCT04168229 — A Clinical Investigation of the Benefit: BTE Hearing Aids Versus ITE Hearing Aids · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03498274 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bernafon AG
- Last refreshed: 23 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03498274.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing